ALFA Finder| Value | ₹0.05 Cr |
|---|
BSE filing, NSE: AARTIPHARM. Summary written from the filing by ALFA Finder's alert engine.
Aarti Pharmalabs Ltd: key numbers
- Share price
- ₹929.10
- Market cap
- ₹8,425 Cr
- Revenue (annual)
- ₹1,819 Cr
- Net profit (annual)
- ₹174.7 Cr
- P/E (TTM)
- 32.8×Sector 43.0×
- Promoter holding
- 39.66%-3.20% QoQ
- FII holding
- 8.16%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aarti Pharmalabs Ltd
All →Aarti Pharmalabs Earnings Call Transcript: Key Takeaways
Aarti Pharmalabs delivered record quarterly revenue driven by strong CDMO growth, though aggressive capex is temporarily elevating debt and working capital.
- Call
- Guides 45% growth
Aarti Pharmalabs Investor Presentation: Key Takeaways
Q2 FY27 standalone revenue INR 6,126Mn (+46.8% YoY), EBITDA INR 1,358Mn (22.2% margin), PAT INR 658Mn (+180% YoY). H1 revenue +44.7%. Xanthine capacity expansion and Atali capex drive growth.
Aarti Pharmalabs Management Change
Aarti Pharmalabs accepted CFO Piyush Lakhani's resignation, effective 30 October 2026, and appointed Vibha Thakker as CFO from 31 October 2026. The filing records a senior management change with no monetary amount.
Aarti Pharmalabs Q2 FY27 Results: Net Profit ₹71.5 Cr, Up 248.8% YoY
Aarti Pharmalabs Ltd reported revenue from operations of ₹610.5 Cr (+45.9% YoY) and net profit of ₹71.5 Cr (+248.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹71.5 Cr · +248.8% YoY
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
Other promoter selling announcements
All →Sri Lotus Developers and Realty Promoter Selling: ₹573 Cr
Promoter Anand Kamalnayan Pandit sold 2.39 crore shares via NSE market sale, worth Rs.572.96 Crore. Promoter holding falls from 70.03% to 65.14%.
- Value
- ₹573.0 Cr
Womancart Promoter Selling: ₹1.98 Cr
Promoters Madhu Sudan and Prerna Pahwa sold 2.5 lakh Womancart shares on NSE for Rs.1.98 Crore. Madhu Sudan's stake fell to 4.15% and Prerna's to 2.37%.
- Value
- ₹1.98 Cr
Kapston Services Promoter Selling: ₹0.82 Cr
Promoter Srikanth Kodali sold 16,265 Kapston shares (0.05%) on the open market on November 4, 2026. His holding fell from 63.45% to 63.40%.
- Value
- ₹0.82 Cr
Shreeji Shipping Global Promoter Selling: ₹256.5 Cr
Promoters Ashokkumar and Jitendra Haridas Lal sold 30,00,000 shares through the NSE OFS window on 3-4 November 2026. Combined sale value is about INR 256.54 Crore.
- Value
- ₹256.5 Cr
Gallantt Ispat Promoter Selling
Promoter Dinesh R. Agarwal sold 3,89,708 Gallantt Ispat shares, reducing holding to 5.65%. The filing's sale mode conflicts with its gift note, so no value is taken.
Sri Lotus Developers and Realty Promoter Selling
Promoter Anand Pandit is exercising an oversubscription option to sell 27,04,182 more shares via exchanges. Total offer rises to 2.65 crore shares, 5.42% of equity.
- Execution
- T day November 03, 2026 (non-retail) and T+1 November 04, 2026 (retail and carry-forward bids)